IMMUNOME INC (IMNM) Stock Earnings Estimates
NASDAQ:IMNM • US45257U1088
22.16 USD
-0.28 (-1.25%)
At close: Feb 13, 2026
22.1 USD
-0.06 (-0.27%)
After Hours: 2/13/2026, 8:17:20 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 14.018M | 9.041M -35.50% | 7.375M -18.43% | 8.225M 11.53% | 82.199M 899.38% | 175.57M 113.59% | 356.02M 102.78% | 553.62M 55.50% | 853.99M 54.26% | 1.126B 31.85% | 1.393B 23.71% | ||
| EBITDA YoY % growth | -36.48M -49.26% | -28.271M 22.50% | -151.889M -437.26% | -214.205M -41.03% | -268.398M -25.30% | -251.801M 6.18% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -36.9M -46.43% | -28.728M 22.15% | -153.456M -434.17% | -213.835M -39.35% | -271.212M -26.83% | -259.349M 4.37% | -165.048M 36.36% | -7.729M 95.32% | 166.86M 2,258.83% | 346.53M 107.68% | 562.26M 62.25% | 748.92M 33.20% | |
| Operating Margin | N/A | -204.94% | -1,697.33% | -2,899.46% | -3,297.41% | -315.51% | -94.01% | -2.17% | 30.14% | 40.58% | 49.93% | 53.76% | |
| EPS YoY % growth | -3.09 -43.06% | N/A 67.94% | -5.17 -421.82% | -2.32 55.17% | -2.67 -15.40% | -2.31 13.71% | -1.11 51.97% | 0.63 156.90% | 2.35 273.07% | 4.01 70.23% | 4.62 15.28% | 5.12 10.90% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.61 52.51% | -0.61 -17.47% | -0.62 -24.28% | -0.66 -1.39% | -0.61 -0.25% | -0.57 6.49% | -0.55 12.02% | -0.46 30.66% | -0.37 39.75% |
| Revenue Q2Q % growth | 339.997K -87.58% | -100.00% | -100.00% | -100.00% | 11.571M | 4.126M | 13.495M | 24.803M | |
| EBITDA Q2Q % growth | -61.131M -13.14% | -59.568M -35.30% | -54.5M -20.49% | -64.218M -10.15% | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -62.136M -11.76% | -60.588M -35.74% | -62.271M -33.98% | -67.354M -12.00% | -62.689M -0.89% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.65 16.67% | -0.59 | -0.06 | -10.97% |
| Q2 2025 Q2Q % growth | -0.50 16.67% | -0.54 | 0.04 | 7.32% |
| Q1 2025 Q2Q % growth | -0.52 79.28% | -0.69 | 0.17 | 25.15% |
| Q4 2024 Q2Q % growth | -1.28 69.67% | -0.59 | -0.69 | -116.80% |
| Q3 2024 Q2Q % growth | -0.78 -349.83% | -0.57 | -0.21 | -36.96% |
| Q2 2024 Q2Q % growth | -0.60 -30.43% | -0.40 | -0.20 | -49.55% |
| Q1 2024 Q2Q % growth | -2.51 -617.14% | -0.71 | -1.80 | -254.68% |
| Q4 2023 Q2Q % growth | -4.22 -559.37% | -0.29 | -3.93 | -1,360.22% |
| Q3 2023 Q2Q % growth | 76.88% | -0.17 | % | |
| Q2 2023 Q2Q % growth | -0.46 37.84% | -0.16 | -0.30 | -181.86% |
| Q1 2023 Q2Q % growth | -0.35 63.54% | 0.60 | -0.95 | -158.66% |
| Q4 2022 Q2Q % growth | -0.64 5.88% | -0.69 | 0.05 | 7.04% |
| Q3 2022 Q2Q % growth | -0.75 -15.38% | -0.78 | 0.03 | 3.25% |
| Q2 2022 Q2Q % growth | -0.74 -60.87% | -0.77 | 0.03 | 3.27% |
| Q1 2022 Q2Q % growth | -0.96 -159.46% | -0.70 | -0.26 | -36.40% |
| Q4 2021 Q2Q % growth | -0.68 -70.00% | -0.83 | 0.15 | 17.70% |
| Q3 2021 Q2Q % growth | -0.65 91.36% | -0.51 | -0.14 | -27.45% |
| Q2 2021 Q2Q % growth | -0.46 | -0.40 | -0.06 | -15.64% |
| Q1 2021 Q2Q % growth | -0.37 | -0.42 | 0.05 | 11.53% |
| Q4 2020 Q2Q % growth | -0.40 | -0.30 | -0.10 | -35.23% |
| Q3 2020 Q2Q % growth | -7.52 | -0.39 | -7.13 | -1,840.14% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -100.00% | 816K | -816K | -100.00% |
| Q2 2025 Q2Q % growth | 4.015M 69.84% | 728.576K | 3.286M | 451.08% |
| Q1 2025 Q2Q % growth | 2.926M 184.35% | 291.424K | 2.635M | 904.03% |
| Q4 2024 Q2Q % growth | 2.738M -28.44% | 3.219M | -481K | -14.94% |
| Q3 2024 Q2Q % growth | 2.91M -18.49% | 2.176M | 734K | 33.73% |
| Q2 2024 Q2Q % growth | 2.364M -44.55% | 2.601M | -237K | -9.11% |
| Q1 2024 Q2Q % growth | 1.029M | 2.856M | -1.827M | -63.97% |
| Q4 2023 Q2Q % growth | 3.826M | 2.111M | 1.715M | 81.24% |
| Q2 2021 Q2Q % growth | 3.857M | -3.857M | -100.00% | |
| Q1 2021 Q2Q % growth | 2.639M | -2.639M | -100.00% | |
| Q4 2020 Q2Q % growth | 2.142M | -2.142M | -100.00% | |
| Q3 2020 Q2Q % growth | 398.31K | -398.31K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -5.38% | 0.17% | -6.12% |
| Revenue | 0% | -60.53% | 0% | -4.05% |